Summary
This prediction ended on 23.01.26 with a price of €4.84. The prediction for Altimmune disappointed with a performance of -27.45%. HC_Wainwright has a follow-up prediction for Altimmune where he still thinks Altimmune is a Buy. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Altimmune | -1.177% | -1.177% | -26.470% |
| iShares Core DAX® | -0.436% | 1.181% | 14.210% |
| iShares Nasdaq 100 | 0.854% | 1.475% | 5.797% |
| iShares Nikkei 225® | 2.652% | 6.401% | 19.133% |
| iShares S&P 500 | 1.190% | 1.169% | 2.686% |
Comments by HC_Wainwright for this prediction
In the thread Altimmune diskutieren
Altimmune, Inc. (NASDAQ: ALT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Ratings data for ALT provided by MarketBeat
In the thread Trading Altimmune
Die von HC_Wainwright gewählte maximale Laufzeit wurde überschritten

